Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
2,58 USD | +6,61 % | +12,17 % | +45,76 % |
Resumen de negocios
Número de empleados: 52
Ventas por actividad
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Adeno-Associated Viruses-based Gene Therapies
100,0
%
| 3 | 100,0 % | 15 | 100,0 % | +517,55 % |
Ventas por región
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 3 | 100,0 % | 15 | 100,0 % | +517,55 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Sean Nolan
CEO | Chief Executive Officer | 56 | 01/03/20 |
Kamran Alam
DFI | Director of Finance/CFO | 46 | 01/08/20 |
President | 58 | 01/07/20 | |
Fred Porter
CTO | Chief Tech/Sci/R&D Officer | - | - |
Jim Rouse
CTO | Chief Tech/Sci/R&D Officer | - | - |
Sean McAuliffe
PRN | Corporate Officer/Principal | - | 01/06/20 |
Emily McGinnis
LAW | General Counsel | - | 01/04/20 |
Tracy M. Porter
HRO | Human Resources Officer | - | 26/01/21 |
Mary Newman
PRN | Corporate Officer/Principal | 65 | 13/05/21 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Philip Donenberg
BRD | Director/Board Member | 63 | 31/08/20 |
Sean Nolan
CEO | Chief Executive Officer | 56 | 01/03/20 |
Sean Stalfort
BRD | Director/Board Member | 54 | 21/06/23 |
President | 58 | 01/07/20 | |
Director/Board Member | 63 | 23/11/20 | |
Alison Long
BRD | Director/Board Member | - | 01/11 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 187 018 275 | 140 693 475 ( 75,23 %) | 0 | 75,23 % |
Información de la empresa
Sector
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
+45,76 % | 453 M | |
+26,28 % | 42,68 mil M | |
-3,99 % | 42,4 mil M | |
+45,32 % | 40,04 mil M | |
-6,20 % | 28,31 mil M | |
+6,36 % | 24,94 mil M | |
-21,47 % | 18,96 mil M | |
+27,58 % | 12,3 mil M | |
-2,75 % | 11,95 mil M | |
-2,02 % | 11,55 mil M |
- Bolsa de valores
- Acciones
- Acción TSHA
- Empresa Taysha Gene Therapies, Inc.